We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current AFME market cap is 59M. The company's latest EPS is EUR -0.4594 and P/E is -3.87.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 2.03M | 1.45M | 870k | 1.58M | 1.37M |
| Operating Income | -13.22M | -15.03M | -12.87M | -13.27M | -14.28M |
| Net Income | -11.25M | -16.59M | -14.32M | -14.82M | -15.23M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 71.89M | 65.25M | 64.83M | 70.04M | 60.02M |
| Total Liabilities | 23.39M | 34.29M | 29.54M | 26.5M | 26.19M |
| Total Equity | 48.51M | 30.96M | 35.29M | 43.54M | 33.83M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -9.33M | -11.41M | -8.94M | -12.36M | -11.08M |
| Investing | -2.06M | -185k | -304k | -160k | -146k |
| Financing | 9.74M | 10.39M | 12.76M | 18.28M | 2.4M |
| Market Cap | 59M |
| Price to Earnings Ratio | -3.87 |
| Price to Sales Ratio | 42.89 |
| Price to Cash Ratio | 22.88 |
| Price to Book Ratio | 1.74 |
| Dividend Yield | - |
| Shares Outstanding | 33.15M |
| Average Volume (1 week) | 4.37k |
| Average Volume (1 Month) | 3.73k |
| 52 Week Change | 36.92% |
| 52 Week High | 2.30 |
| 52 Week Low | 0.93 |
| Spread (Intraday) | 0.01 (0.28%) |
| Company Name | Affluent Medical |
| Address |
320 avenue archimede aix-en-provence, bouches-du-rhone 13100 |
| Website | https://www.affluentmedical.com |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
